Steven Pearson

Last updated

Steven Pearson is an American physician, bioethicist, and the Founder and President of the non-profit health policy and comparative effectiveness research organization Institute for Clinical and Economic Review in Boston, MA. [1] He conducts research on cost-effectiveness analysis and healthcare technology assessment. He is also a lecturer in Harvard's Department of Population Medicine and a member of the National Institutes of Health (NIH) Comparative Effectiveness Research Steering Committee. [2]

Career and education

Pearson founded the Institute for Clinical and Economic Review at the Massachusetts General Hospital's Institute for Technology Assessment in 2006. Prior to that, he was a fellow at America's Health Insurance Plans (AHIP). [3] He also received an Atlantic Fellowship and was a Senior Fellow in the United Kingdom at the National Institute for Health and Care Excellence of the UK's National Health Service. Additionally he has been a member of the Coverage and Analysis Group at the Centers for Medicare and Medicaid Services (CMS) in the United States. He is the author of the book No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence, published by Oxford University Press along with James Sabin and Ezekiel Emanuel. [4]

Pearson's medical degree is from the UCSF School of Medicine and he completed a residency in internal medicine at Brigham and Women’s Hospital. In addition to a medical degree, he holds a Master of Science Degree in Health Policy and Management from the Harvard School of Public Health. [5]

Pearson has authored many articles related to health policy debates and issues at the national level as well as articles that speak to cost effectiveness of specific health care technologies. [6] In 2010, he co-authored an article in Health Affairs with Memorial Sloan Kettering's Peter Bach that stated "Medicare must find new ways to achieve cost control without limiting access to beneficial services." [7]

Related Research Articles

Utilitarian bioethics refers to the branch of bioethics that incorporates principles of utilitarianism to directing practices and resources where they will have the most usefulness and highest likelihood to produce happiness, in regards to medicine, health, and medical or biological research.

<span class="mw-page-title-main">Mark McClellan</span> American health economist (born 1963)

Mark Barr McClellan is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004, and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.

The Declaration of Helsinki is a set of ethical principles regarding human experimentation developed originally in 1964 for the medical community by the World Medical Association (WMA). It is widely regarded as the cornerstone document on human research ethics.

<span class="mw-page-title-main">The Hastings Center</span> Non-profit organization in the USA

The Hastings Center is an independent, nonpartisan bioethics research institute and think tank based in Garrison, New York. It was instrumental in establishing the field of bioethics and is among the most prestigious bioethics and health policy institutes in the world.

<span class="mw-page-title-main">Ezekiel Emanuel</span> American oncologist and bioethicist

Ezekiel Jonathan "Zeke" Emanuel is an American oncologist, bioethicist and senior fellow at the Center for American Progress. He is the current Vice Provost for Global Initiatives at the University of Pennsylvania and chair of the Department of Medical Ethics and Health Policy. Previously, Emanuel served as the Diane and Robert Levy University Professor at Penn. He holds a joint appointment at the University of Pennsylvania School of Medicine and the Wharton School and was formerly an associate professor at the Harvard Medical School until 1998 when he joined the National Institutes of Health.

Christine K. Cassel is a leading expert in geriatric medicine, medical ethics and quality of care. She is planning dean of the new Kaiser Permanente School of Medicine. Until March 2016, she was president and CEO of the National Quality Forum. Previously, Cassel served as president and CEO of the American Board of Internal Medicine (ABIM) and the ABIM Foundation.

<span class="mw-page-title-main">Donald Berwick</span> American government official

Donald M. Berwick is a former Administrator of the Centers for Medicare and Medicaid Services (CMS). Prior to his work in the administration, he was President and Chief Executive Officer of the Institute for Healthcare Improvement a not-for-profit organization.

Leighton Chan is an American medical researcher and rehabilitation physician. He is Chief of the Rehabilitation Medicine Department and Acting Chief Scientific Officer/Scientific Director at the National Institutes of Health Clinical Center.

Comparative effectiveness research (CER) is the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms. The core question of comparative effectiveness research is which treatment works best, for whom, and under what circumstances. Engaging various stakeholders in this process, while difficult, makes research more applicable through providing information that improves patient decision making.

<span class="mw-page-title-main">Norman Daniels</span> American ethicist (born 1942)

Norman Daniels is an American political philosopher and philosopher of science, political theorist, ethicist, and bioethicist at Harvard University and the Harvard T.H. Chan School of Public Health. Before his career at Harvard, Daniels had built his career as a medical ethicist at Tufts University in Medford, Massachusetts, and at Tufts University School of Medicine, also in Boston. He also developed the concept of accountability for reasonableness with James Sabin, an ethics framework used to challenge the healthcare resource allocation in the 1990s.

Michael Alan Grodin is Professor of Health Law, Bioethics, and Human Rights at the Boston University School of Public Health, where he has received the distinguished Faculty Career Award for Research and Scholarship, and 20 teaching awards, including the "Norman A. Scotch Award for Excellence in Teaching." He is also Professor of Family Medicine and Psychiatry at the Boston University School of Medicine. In addition, Dr. Grodin is the Director of the Project on Medicine and the Holocaust at the Elie Wiesel Center for Judaic Studies, and a member of the faculty of the Division of Religious and Theological Studies. He has been on the faculty at Boston University for 35 years. He completed his B.S. degree at the Massachusetts Institute of Technology, his M.D. degree from the Albert Einstein College of Medicine, and his postdoctoral and fellowship training at UCLA and Harvard University.

<span class="mw-page-title-main">Patient-Centered Outcomes Research Institute</span> Health research organization

The Patient-Centered Outcomes Research Institute (PCORI) is a United States-based non-profit institute created through the 2010 Patient Protection and Affordable Care Act. It is a government-sponsored organization charged with funding Comparative Effectiveness Research (CER) that assists consumers, clinicians, purchasers, and policymakers to make informed decisions intended to improve health care at both the individual and population levels, according to the Institute of Medicine. Medicare considers the Institute's research in determining what sorts of therapies it will cover, although the institute's authorizing legislation set certain limits on uses of the research by federal health agencies.

Unnecessary health care is health care provided with a higher volume or cost than is appropriate. In the United States, where health care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its health care spending in 2012.

International Diabetes Center at Park Nicollet (IDC) is a center for diabetes care, research and education located in Minneapolis, Minnesota, United States. The center provides clinical, motivational and educational services for people with diabetes. It is part of HealthPartners Institute.

<span class="mw-page-title-main">Peter Bach</span> Medical researcher

Peter B. Bach is a physician and writer at Memorial Sloan-Kettering Cancer Center where he is Director of the Center for Health Policy and Outcomes. His research focuses on healthcare policy, particularly as it relates to Medicare, racial disparities in cancer care quality, and lung cancer. Along with his scientific writings he is a frequent contributor to The New York Times and other newspapers.

<span class="mw-page-title-main">David O. Meltzer</span>

David Owen Meltzer is a Professor of Medicine at the University of Chicago. He holds faculty appointments in the Department of Medicine, Department of Economics and the Harris School of Public Policy Studies. He is Chief of the Section of Hospital Medicine at the University of Chicago Medicine, and is the Director of the Center for Health and the Social Sciences (CHeSS), as well as the Director of the Urban Health Lab in Chicago, IL. In 2015 he was appointed a member of the faculty for the forthcoming Barack Obama Presidential Center which will be located in Chicago's South Side.

The Institute for Clinical and Economic Review (ICER) is a Boston-based independent nonprofit organization that seeks to place a value on medical care by providing comprehensive clinical and cost-effectiveness analyses of treatments, tests, and procedures.

Yuting Zhang is a professor of health economics at the University of Melbourne, and an expert on economic evaluations of health policy and healthcare reforms. She is a journal editor, award recipient, and has written numerous articles in influential journals in her field.

Jessica Wilen Berg is an American attorney and specialist in Public Health (MPH), currently serving as co-Dean at Case Western Reserve University School of Law, the first female co-Dean or Dean in the law school's 129-year history. She is also Tom J.E. and Bette Lou Walker Professor of Law,Professor in the Departments of Bioethics, and of Population and Quantitative Health Sciences at the CWRU School of Medicine. She is a reference book author in the area of informed consent. Her scholarly opinion is often reported by institutions and media on ethical aspects iof innovative biomedical procedures.

Nancy Keating is an American physician who works at the Brigham and Women's Hospital and is a professor at Harvard Medical School. Her research considers the factors that influence quality care for people suffering from cancer.

References

  1. "ICER: Senior Leadership: Steven D. Pearson, MD, MSc".
  2. "The Department of Bioethics - Our People". bioethics.nih.gov. Retrieved 2016-09-27.
  3. Plans, America's Health Insurance. "AHIP Welcomes Steven Pearson, MD, MSc as a Senior Fellow". www.prnewswire.com. Retrieved 2016-09-27.
  4. Pearson, Steven D.; Sabin, James; Emanuel, Ezekiel J. (2003-08-21). No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence (1 ed.). Oxford; New York: Oxford University Press. ISBN   9780195158960.
  5. "Steven D. Pearson, MD, MSc – ICER". icer-review.org. Retrieved 2016-09-27.
  6. Kazi, Dhruv S.; Moran, Andrew E.; Coxson, Pamela G.; Penko, Joanne; Ollendorf, Daniel A.; Pearson, Steven D.; Tice, Jeffrey A.; Guzman, David; Bibbins-Domingo, Kirsten (2016-08-16). "Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease". JAMA. 316 (7): 743–753. doi: 10.1001/jama.2016.11004 . ISSN   1538-3598. PMID   27533159.
  7. Pearson, Steven D.; Bach, Peter B. (2010-10-01). "How Medicare Could Use Comparative Effectiveness Research In Deciding On New Coverage And Reimbursement". Health Affairs. 29 (10): 1796–1804. doi:10.1377/hlthaff.2010.0623. ISSN   0278-2715. PMID   20921478.